Development and pilot-testing of the expanded prostate index composite - Filipino version (EPIC-F).

Autor: Bacorro W; Department of Clinical Epidemiology, Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.; Department of Radiation Oncology, Benavides Cancer Institute, University of Santo Tomas Hospital, Manila, Philippines., Tordesillas D; Center for Translation and Translation Studies, University of Santo Tomas, Manila, Philippines., Dumago M; Department of Radiation Oncology, Benavides Cancer Institute, University of Santo Tomas Hospital, Manila, Philippines., Trogo JD; Center for Translation and Translation Studies, University of Santo Tomas, Manila, Philippines.; Department of Filipino, College of Education, University of Santo Tomas, Manila, Philippines., Mendoza E; Center for Translation and Translation Studies, University of Santo Tomas, Manila, Philippines.; Department of Filipino, College of Education, University of Santo Tomas, Manila, Philippines., Alpajaro SI; Urologic Oncology Unit, Section of Urology, Department of Surgery, Benavides Cancer Institute, University of Santo Tomas Hospital, Manila, Philippines., Arcinas R; Department of Surgery, Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines., Fajilan W; Center for Translation and Translation Studies, University of Santo Tomas, Manila, Philippines.; Department of Filipino, College of Education, University of Santo Tomas, Manila, Philippines.
Jazyk: angličtina
Zdroj: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2023 Aug; Vol. 19 (4), pp. 517-524. Date of Electronic Publication: 2022 Dec 04.
DOI: 10.1111/ajco.13894
Abstrakt: Introduction: Quality-of-life (QOL) is paramount in clinical decision-making in the management of prostate cancer patients. The expanded prostate index composite (EPIC) is a widely used and well-validated QOL tool that allows for the evaluation of bowel, urinary, sexual, and hormonal domains. A Filipino translation was previously lacking. We describe the development and pilot testing of the Filipino translation of the EPIC (EPIC-F).
Methodology: The EPIC-32 was translated into Filipino using iterative forward and backward procedures with checks for semantic congruency. The translation was then evaluated by an expert panel consisting of a prostate cancer survivor and pertinent health professionals. A focused group discussion (FGD) was conducted to explore sources of difficulty of use to guide improvement.
Results: The linguistically validated translation was evaluated to have cultural relevancy, adequacy, and representativeness by the expert panel, and to have good understandability and answerability by a representative pilot cohort of prostate cancer patients. Seven unsatisfactory items were identified, all pertaining to the sexual domain, and required minimal revision on review during the FGD.
Conclusion: The EPIC-F is a linguistically and culturally validated version of the EPIC 32, with good understandability and answerability, permitting clinical use. Its psychometric properties need to be determined to define its utility in clinical research.
(© 2022 John Wiley & Sons Australia, Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje